RHIM Rhi Magnesita India Q4 FY25 results (Jan–Mar 2025) and concall
RHI Magnesita reported a challenging Q4 and FY25 with revenue decline and margin compression due to intense competition, rising input costs, and overcapacity. However, the company achieved a significant PAT turnaround for FY25 and substantially reduced its net debt. Management remains optimistic for FY26, driven by strategic initiatives, new product introductions, and expected recovery in key end-user sectors, while actively addressing market commoditization and cost pressures.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 661 | 774 | 755 |
| EBITDA | 87 | 97 | 73 |
| Net profit | 49 | 56 | 36 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
